Literature DB >> 22419268

Morin protects heart from beta-adrenergic-stimulated myocardial infarction: an electrocardiographic, biochemical, and histological study in rats.

Bharath Kumar Pogula1, Mari Kannan Maharajan, Divya Rekha Oddepalli, Lavanya Boini, Mounika Arella, Darlin Quine Sabarimuthu.   

Abstract

In recent years, polyphenols have attracted considerable attention as agents that protect cells or molecules from oxidative myocardial injury. The aim of the study was to prove the cardioprotective benefits of the flavonoid morin in isoproterenol-induced myocardial infarcted rats. Male Wistar rats are treated orally with morin (10 and 20 mg/kg) daily for a period of 21 days. After 21 days of pretreatment, isoproterenol (100 mg/kg) was injected subcutaneously to rats at an interval of 24 h for 2 days to induce myocardial infarction. Electrocardiographical abnormalities and biomarkers were measured in normal and experimental rats. Isoproterenol-induced myocardial infarcted rats showed significant (p<0.05) increase in the levels of cardiac markers. Pretreatment with morin regulated the abnormalities in electrocardiograph and biomarkers. The lipid peroxidation products were increased and indicated the increased lipid peroxidation in isoproterenol-induced myocardial infarcted rats. The rats pretreated with morin significantly reduced lipid peroxidation. The altered lipid metabolism was observed in isoproterenol-induced myocardial infarcted rats and in pretreatment with morin-regulated lipid metabolism. Histopathological study evidenced that the pretreatment with morin inhibited myocardial damage. The results of this study proved the protective effect of morin as pretreatment and are rational to understand the beneficial effects of morin on cardioprotection against myocardial injury. Based on the results, the cardioprotective ability of morin on human beings can be studied in the future.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22419268     DOI: 10.1007/s13105-012-0157-z

Source DB:  PubMed          Journal:  J Physiol Biochem        ISSN: 1138-7548            Impact factor:   4.158


  42 in total

1.  Antioxidant activity applying an improved ABTS radical cation decolorization assay.

Authors:  R Re; N Pellegrini; A Proteggente; A Pannala; M Yang; C Rice-Evans
Journal:  Free Radic Biol Med       Date:  1999-05       Impact factor: 7.376

2.  Protective effect of n-3 polyunsaturated fatty acids concentrate on isoproterenol-induced myocardial infarction in rats.

Authors:  R Anandan; Suseela Mathew; T V Sankar; P G Viswanathan Nair
Journal:  Prostaglandins Leukot Essent Fatty Acids       Date:  2007-02-01       Impact factor: 4.006

3.  Sequential changes of energy metabolism and mitochondrial function in myocardial infarction induced by isoproterenol in rats: a long-term and integrative study.

Authors:  V Chagoya de Sánchez; R Hernández-Muñoz; F López-Barrera; L Yañez; S Vidrio; J Suárez; M D Cota-Garza; A Aranda-Fraustro; D Cruz
Journal:  Can J Physiol Pharmacol       Date:  1997-12       Impact factor: 2.273

4.  Decreased HDL2 and HDL3 cholesterol, Apo A-I and Apo A-II, and increased risk of myocardial infarction.

Authors:  J E Buring; G T O'Connor; S Z Goldhaber; B Rosner; P N Herbert; C B Blum; J L Breslow; C H Hennekens
Journal:  Circulation       Date:  1992-01       Impact factor: 29.690

5.  Experimental myocardial necrosis in rats: role of arjunolic acid on platelet aggregation, coagulation and antioxidant status.

Authors:  M Sumitra; P Manikandan; D A Kumar; N Arutselvan; K Balakrishna; B M Manohar; R Puvanakrishnan
Journal:  Mol Cell Biochem       Date:  2001-08       Impact factor: 3.396

6.  Preventive effects of rutin on lysosomal enzymes in isoproterenol induced cardio toxic rats: biochemical, histological and in vitro evidences.

Authors:  Ponnian Stanely Mainzen Prince; Shanmuga Priya
Journal:  Eur J Pharmacol       Date:  2010-09-17       Impact factor: 4.432

7.  Effects of catecholamines on myocardial endogenous substrates and contractility.

Authors:  M F Crass; J C Shipp; G M Pieper
Journal:  Am J Physiol       Date:  1975-02

8.  Pretreatment with a combination of quercetin and alpha-tocopherol ameliorates adenosine triphosphatases and lysosomal enzymes in myocardial infarcted rats.

Authors:  V R Punithavathi; P Stanely Mainzen Prince
Journal:  Life Sci       Date:  2009-12-01       Impact factor: 5.037

Review 9.  Influence of free fatty acids on myocardial oxygen consumption and ischemic injury.

Authors:  H Vik-Mo; O D Mjøs
Journal:  Am J Cardiol       Date:  1981-08       Impact factor: 2.778

10.  Effect of squalene on tissue defense system in isoproterenol-induced myocardial infarction in rats.

Authors:  K H Sabeena Farvin; R Anandan; S Hari Senthil Kumar; K S Shiny; T V Sankar; T K Thankappan
Journal:  Pharmacol Res       Date:  2004-09       Impact factor: 7.658

View more
  4 in total

1.  Morin Augmented Myocardial eNOS/cGMP/PKG Signaling Pathway and Abated Oxidative and Inflammo-apoptotic Responses in Diethyl Phthalate and Bisphenol-S Co-Exposed Male Albino Rats.

Authors:  Adewale Segun James; Ofem Effiom Eteng; Oluwatosin Adebisi Dosumu; Ceasar Antiya Moses; Chukwuka Uzoamaka Ogbonna; Oladokun Abdulwasiu Adeleye; Emmanuel Ifeanyichukwu Ugwor; Blessing Chukwueku Omilo; Risikat Funmilayo Fabunmi; Aduragbemi Moses Olakitan; Regina Ngozi Ugbaja
Journal:  Inflammation       Date:  2022-07-28       Impact factor: 4.657

2.  High intake of dietary tyramine does not deteriorate glucose handling and does not cause adverse cardiovascular effects in mice.

Authors:  Christian Carpéné; Stéphane Schaak; Céline Guilbeau-Frugier; Josep Mercader; Jeanne Mialet-Perez
Journal:  J Physiol Biochem       Date:  2015-12-03       Impact factor: 4.158

3.  Cardioprotective Effect of Licochalcone D against Myocardial Ischemia/Reperfusion Injury in Langendorff-Perfused Rat Hearts.

Authors:  Xuan Yuan; Hai-tao Niu; Peng-long Wang; Jie Lu; Hong Zhao; Shi-han Liu; Qiu-sheng Zheng; Chang-gui Li
Journal:  PLoS One       Date:  2015-06-09       Impact factor: 3.240

4.  Alleviating effects of morin against experimentally-induced diabetic osteopenia.

Authors:  Hatem M Abuohashish; Salim S Al-Rejaie; Khaled A Al-Hosaini; Mihir Y Parmar; Mohammed M Ahmed
Journal:  Diabetol Metab Syndr       Date:  2013-02-06       Impact factor: 3.320

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.